StonvexLoading…
StonvexStonvexStonvexCore line items from TRNR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $11.53M | $5.38M | $962.00K | $681.00K |
Operating Income | $-19.86M | $-29.18M | $-54.48M | $-54.34M |
Net Income | $-23.97M | $-34.93M | $-51.37M | $-58.23M |
EPS (Diluted) | $-171.77 | $-16328.50 | $-16614.85 | $-119.49 |
Total Assets | $46.84M | $34.17M | $16.80M | $24.45M |
Total Liabilities | $38.15M | $27.05M | $22.35M | $27.18M |
Cash & Equivalents | $512.00K | $138.00K | $0.00 | $226.00K |
Free Cash Flow OCF − CapEx | $-10.50M | $-14.81M | $-15.43M | $-36.12M |
Shares Outstanding | 307.52K | 14.02K | 3.55K | 2.45M |